The International Cancer Benchmarking Partnership: An international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom

被引:87
作者
Butler, John [1 ,2 ]
Foot, Catherine [3 ]
Bomb, Martine [2 ]
Hiom, Sara [2 ]
Coleman, Michel [4 ]
Bryant, Heather [5 ]
Vedsted, Peter [6 ]
Hanson, Jane [7 ]
Richards, Mike [8 ]
机构
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] Canc Res UK, London EC1V 4AD, England
[3] Kings Fund, London W1G 0AN, England
[4] London Sch Hyg & Trop Med, Canc Res UK Canc Survival Grp, London WC1E 7HT, England
[5] Canadian Partnership Canc, Toronto, ON M5J 2P1, Canada
[6] Sch Publ Hlth, Danish Res Ctr Canc Diag Primary Care CaP, Res Unit Gen Practice, DK-8000 Aarhus, Denmark
[7] Natl Specialist Advisory Grp Core Team, Cardiff CF11 9LH, S Glam, Wales
[8] Natl Canc Act Team, London SW1E 5RS, England
关键词
International comparisons; Cancer survival; Cancer policy; Benchmarking; COLORECTAL-CANCER; BREAST-CANCER; HIGH-RESOLUTION; SURVIVAL; DIAGNOSIS; STAGE; DELAY; COUNTRIES; ENGLAND; EUROPE;
D O I
10.1016/j.healthpol.2013.03.021
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The International Cancer Benchmarking Partnership (ICBP) was initiated by the Department of Health in England to study international variation in cancer survival, and to inform policy to improve cancer survival. It is a research collaboration between twelve jurisdictions in six countries: Australia (New South Wales, Victoria), Canada (Alberta, British Columbia, Manitoba, Ontario), Denmark, Norway, Sweden, and the United Kingdom (England, Northern Ireland, Wales). Leadership is provided by policymakers, with academics, clinicians and cancer registries forming an international network to conduct the research. The project currently has five modules examining: (1) cancer survival, (2) population awareness and beliefs about cancer, (3) attitudes, behaviours and systems in primary care, (4) delays in diagnosis and treatment, and their causes, and (5) treatment, co-morbidities and other factors. These modules employ a range of methodologies including epidemiological and statistical analyses, surveys and clinical record audit. The first publications have already been used to inform and develop cancer policies in participating countries, and a further series of publications is under way. The module design, governance structure, funding arrangements and management approach to the partnership provide a case study in conducting international comparisons of health systems that are both academically and clinically robust and of immediate relevance to policymakers. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:148 / 155
页数:8
相关论文
共 41 条
  • [1] What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
    Abdel-Rahman, M.
    Stockton, D.
    Rachet, B.
    Hakulinen, T.
    Coleman, M. P.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 : S115 - S124
  • [2] Allemani C, 2012, INT J CANC
  • [3] Variation in 'standard care' for breast cancer across Europe: A EUROCARE-3 high resolution study
    Allemani, Claudia
    Storm, Hans
    Voogd, Adri C.
    Holli, Kaija
    Izarzugaza, Isabel
    Torrella-Ramos, Ana
    Bielska-Lasota, Magdalena
    Aareleid, Tiiu
    Ardanaz, Eva
    Colonna, Marc
    Crocetti, Emanuele
    Danzon, Arlette
    Federico, Massimo
    Garau, Isabel
    Grosclaude, Pascale
    Hedelin, Guy
    Martinez-Garcia, Carmen
    Peignaux, Karin
    Plesko, Ivan
    Primic-Zakelj, Maja
    Rachtan, Jadwiga
    Tagliabue, Giovanna
    Tumino, Rosario
    Traina, Adele
    Tryggvadottir, Laufey
    Vercelli, Marina
    Sant, Milena
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (09) : 1528 - 1536
  • [4] [Anonymous], POL FRAM COMM CANC S
  • [5] The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies
    Berrino, F.
    [J]. ANNALS OF ONCOLOGY, 2003, 14 : V9 - V13
  • [6] Berrino F, 1999, IARC SCI PUBLICATION
  • [7] Berrino F, 1995, IARC SCI PUBLICATION, V132
  • [8] Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
    Berrino, Franco
    De Angelis, Roberta
    Sant, Milena
    Rosso, Stefano
    Lasota, Magdalena B.
    Coebergh, Jan W.
    Santaquilani, Mariano
    [J]. LANCET ONCOLOGY, 2007, 8 (09) : 773 - 783
  • [9] Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
    Coleman, M. P.
    Forman, D.
    Bryant, H.
    Butler, J.
    Rachet, B.
    Maringe, C.
    Nur, U.
    Tracey, E.
    Coory, M.
    Hatcher, J.
    McGahan, C. E.
    Turner, D.
    Marrett, L.
    Gjerstorff, M. L.
    Johannesen, T. B.
    Adolfsson, J.
    Lambe, M.
    Lawrence, G.
    Meechan, D.
    Morris, E. J.
    Middleton, R.
    Steward, J.
    Richards, M. A.
    [J]. LANCET, 2011, 377 (9760) : 127 - 138
  • [10] Cancer survival in five continents: a worldwide population-based study (CONCORD)
    Coleman, Michel P.
    Quaresma, Manuela
    Berrino, Franco
    Lutz, Jean-Michel
    De Angelis, Roberto
    Capocaccia, Riccardo
    Baili, Paolo
    Rachet, Bernard
    Gatta, Gemma
    Hakulinen, Timo
    Micheli, Andrea
    Sant, Milena
    Weir, Hannah K.
    Elwood, J. Mark
    Tsukuma, Hideaki
    Koifman, Sergio
    Azevedo e Silva, Gulnar
    Francisci, Silvia
    Santaquilani, Mariano
    Verdecchia, Arduino
    Storm, Hans H.
    Young, John L.
    [J]. LANCET ONCOLOGY, 2008, 9 (08) : 730 - 756